Table VII.
UCA1 expression | HULC expression | ||||||
---|---|---|---|---|---|---|---|
Characteristics | No. | High group | Low group | P-value | High group | Low group | P-value |
Age (years) | |||||||
<50 | 18 | 5 | 13 | 0.024 | 5 | 13 | 0.024 |
>50 | 42 | 25 | 17 | 25 | 17 | ||
Sex | |||||||
Female | 32 | 17 | 15 | 0.605 | 12 | 20 | 0.038 |
Male | 28 | 13 | 15 | 18 | 10 | ||
Lymphatic metastasis | |||||||
No | 36 | 14 | 22 | 0.035 | 15 | 21 | 0.113 |
Yes | 24 | 16 | 8 | 15 | 9 | ||
Tumor stage | |||||||
Stage I, II | 33 | 12 | 21 | 0.020 | 15 | 18 | 0.436 |
Stage III, IV | 27 | 18 | 9 | 15 | 12 | ||
TNM staging system | |||||||
T1+T2 | 32 | 17 | 15 | 0.605 | 14 | 18 | 0.301 |
T3+T4 | 28 | 13 | 15 | 16 | 12 | ||
CHL1-AS2 expression | LINC00484 expression | ||||||
Characteristics | No. | High group | Low group | P-value | High group | Low group | P-value |
Age (years) | |||||||
<50 | 18 | 8 | 10 | 0.573 | 9 | 9 | 1.000 |
>50 | 42 | 22 | 20 | 21 | 21 | ||
Sex | |||||||
Female | 32 | 20 | 12 | 0.038 | 21 | 11 | 0.009 |
Male | 28 | 10 | 18 | 9 | 19 | ||
Lymphatic metastasis | |||||||
No | 36 | 17 | 19 | 0.598 | 19 | 17 | 0.598 |
Yes | 24 | 13 | 11 | 11 | 13 | ||
Tumor stage | |||||||
Stage I, II | 33 | 16 | 17 | 0.796 | 18 | 15 | 0.436 |
Stage III, IV | 27 | 14 | 13 | 12 | 15 | ||
TNM staging system | |||||||
T1+T2 | 32 | 13 | 19 | 0.120 | 20 | 12 | 0.038 |
T3+T4 | 28 | 17 | 11 | 10 | 18 | ||
CLDN10-AS1 expression | DLX6-AS1 expression | ||||||
Characteristics | No. | High group | Low group | P-value | High group | Low group | P-value |
Age (years) | |||||||
<50 | 18 | 8 | 10 | 0.573 | 7 | 11 | 0.260 |
>50 | 42 | 22 | 20 | 23 | 19 | ||
Sex | |||||||
Female | 32 | 16 | 16 | 1.000 | 15 | 17 | 0.605 |
Male | 28 | 14 | 14 | 15 | 13 | ||
Lymphatic metastasis | |||||||
No | 36 | 21 | 15 | 0.113 | 20 | 16 | 0.292 |
Yes | 24 | 9 | 15 | 10 | 14 | ||
Tumor stage | |||||||
Stage I, II | 33 | 21 | 12 | 0.020 | 11 | 22 | 0.004 |
Stage III, IV | 27 | 9 | 18 | 19 | 8 | ||
TNM staging system | |||||||
T1+T2 | 32 | 18 | 14 | 0.301 | 15 | 17 | 0.605 |
T3+T4 | 28 | 12 | 16 | 15 | 13 | ||
ADAMTS9-AS1 expression | |||||||
Characteristics | No. | High group | Low group | P-value | |||
Age (years) | |||||||
<50 | 18 | 6 | 12 | 0.091 | |||
>50 | 42 | 24 | 18 | ||||
Sex | |||||||
Female | 32 | 17 | 15 | 0.605 | |||
Male | 28 | 13 | 15 | ||||
Lymphatic metastasis | |||||||
No | 36 | 20 | 16 | 0.291 | |||
Yes | 24 | 10 | 14 | ||||
Tumor stage | |||||||
Stage I, II | 33 | 18 | 15 | 0.436 | |||
Stage III, IV | 27 | 12 | 15 | ||||
TNM staging system | |||||||
T1+T2 | 32 | 21 | 11 | 0.010 | |||
T3+T4 | 28 | 9 | 19 |
lncRNAs, long non-coding RNAs.